{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3385, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de074-abc1-773c-9c2f-d49993e7b79a", "docSlug": "59a1ae16b5e60c748be3b046cd750424", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 20 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4138439, "pageNumber": 14, "slideType": "key_takeaways", "function": "summarize", "notes": "Includes a diagram of the CAR-T structure, a waterfall plot for C-CAR031, and a tumor volume line chart for AZD0754.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-abc1-773c-9c2f-d49993e7b79a/14", "deckHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a", "deckAnchorHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "56cdd0e4-2e0f-4301-9ad2-c8da972ed7de", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Details on novel treatments and pipeline advancements aim to satisfy the need with solutions.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-abc1-773c-9c2f-d49993e7b79a", "docSlug": "59a1ae16b5e60c748be3b046cd750424", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 20 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4138439, "pageNumber": 15, "slideType": "cover", "function": "front_matter", "notes": "AstraZeneca branding at #AACR23 conference.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-abc1-773c-9c2f-d49993e7b79a/15", "deckHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a", "deckAnchorHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "56cdd0e4-2e0f-4301-9ad2-c8da972ed7de", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Details on novel treatments and pipeline advancements aim to satisfy the need with solutions.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-abc1-773c-9c2f-d49993e7b79a", "docSlug": "59a1ae16b5e60c748be3b046cd750424", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 20 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4138439, "pageNumber": 16, "slideType": "executive_summary", "function": "establish_context", "notes": "Includes a quote from Stephen Fawell and a diagram illustrating epigenetic mechanisms (histone modification, DNA methylation, RNA interference).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-abc1-773c-9c2f-d49993e7b79a/16", "deckHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a", "deckAnchorHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "56cdd0e4-2e0f-4301-9ad2-c8da972ed7de", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Details on novel treatments and pipeline advancements aim to satisfy the need with solutions.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-abc1-773c-9c2f-d49993e7b79a", "docSlug": "59a1ae16b5e60c748be3b046cd750424", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 20 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4138439, "pageNumber": 17, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes specific study references and definitions for abbreviations like TGI and PDX.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-abc1-773c-9c2f-d49993e7b79a/17", "deckHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a", "deckAnchorHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "56cdd0e4-2e0f-4301-9ad2-c8da972ed7de", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Details on novel treatments and pipeline advancements aim to satisfy the need with solutions.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-abc1-773c-9c2f-d49993e7b79a", "docSlug": "59a1ae16b5e60c748be3b046cd750424", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 20 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4138439, "pageNumber": 18, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-abc1-773c-9c2f-d49993e7b79a/18", "deckHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a", "deckAnchorHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "56cdd0e4-2e0f-4301-9ad2-c8da972ed7de", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Details on novel treatments and pipeline advancements aim to satisfy the need with solutions.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-abc1-773c-9c2f-d49993e7b79a", "docSlug": "59a1ae16b5e60c748be3b046cd750424", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 20 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4138439, "pageNumber": 19, "slideType": "key_messages", "function": "summarize", "notes": "The slide acts as a summary of specific research presentations at AACR.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-abc1-773c-9c2f-d49993e7b79a/19", "deckHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a", "deckAnchorHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "56cdd0e4-2e0f-4301-9ad2-c8da972ed7de", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Details on novel treatments and pipeline advancements aim to satisfy the need with solutions.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-abc1-773c-9c2f-d49993e7b79a", "docSlug": "59a1ae16b5e60c748be3b046cd750424", "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 20 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4138439, "pageNumber": 20, "slideType": "appendix", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-abc1-773c-9c2f-d49993e7b79a/20", "deckHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a", "deckAnchorHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "56cdd0e4-2e0f-4301-9ad2-c8da972ed7de", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Details on novel treatments and pipeline advancements aim to satisfy the need with solutions.", "position": 3, "confidence": 0.7, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/iWxo32m8Hv3NoAHzzLFLTt0uuUSNT6phgCP59yu2Ie4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81ZTY1NjZlNGNkMzdiNWE0YzY3NjYxZTIyOWUwMWE4MS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/1", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "1c5501cd-3c19-4e45-a096-cef5c32ece5b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening slides provide an overview of the Q1 2023 results and the conference call agenda", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/WbWPnt-agtmHDcP5_BzETka8062u5RvTt5dRQDSjQDI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81ZTY1NjZlNGNkMzdiNWE0YzY3NjYxZTIyOWUwMWE4MS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/PXXm7NNmfDWtrDjehjUVTZYVJTKAQysYK7PlKHLe4Ns/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81ZTY1NjZlNGNkMzdiNWE0YzY3NjYxZTIyOWUwMWE4MS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/0_u2q0sC_HJo40Hdtsjpz7XaGGcTWArriOr-SisEh0w/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81ZTY1NjZlNGNkMzdiNWE0YzY3NjYxZTIyOWUwMWE4MS9wMDAxLnBuZw" }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/2", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "1c5501cd-3c19-4e45-a096-cef5c32ece5b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening slides provide an overview of the Q1 2023 results and the conference call agenda", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/3", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "1c5501cd-3c19-4e45-a096-cef5c32ece5b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening slides provide an overview of the Q1 2023 results and the conference call agenda", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "cover", "function": "front_matter", "notes": "Includes a photo of the CEO and a scientific illustration of a virus/cell structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/4", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "1c5501cd-3c19-4e45-a096-cef5c32ece5b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening slides provide an overview of the Q1 2023 results and the conference call agenda", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a navigation bar at the top indicating this is the 'CEO Opening Remarks' section.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/5", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "b9662d01-f7bb-4746-bd60-26f7dc907205", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The slides highlighting financial results and key takeaways demonstrate the need for progress in various business areas", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a horizontal stacked bar chart format to visualize revenue composition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/6", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "b9662d01-f7bb-4746-bd60-26f7dc907205", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The slides highlighting financial results and key takeaways demonstrate the need for progress in various business areas", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a progress-tracking visual to show specific drug candidates and their trial names/indications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/7", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "b9662d01-f7bb-4746-bd60-26f7dc907205", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The slides highlighting financial results and key takeaways demonstrate the need for progress in various business areas", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "section_divider", "function": "transition", "notes": "Includes a headshot of the CFO and a scientific illustration related to the company's field.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/8", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "b9662d01-f7bb-4746-bd60-26f7dc907205", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The slides highlighting financial results and key takeaways demonstrate the need for progress in various business areas", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a standard financial reporting format for quarterly results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/9", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "b9662d01-f7bb-4746-bd60-26f7dc907205", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The slides highlighting financial results and key takeaways demonstrate the need for progress in various business areas", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a standard P&L structure with CER (Constant Exchange Rate) change metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/10", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a waterfall chart for net debt and qualitative guidance for revenue and EPS.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/11", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a horizontal process-like layout to show AI application across the value chain.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/12", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-12", "loopMatches": [ { "to": 14, "from": 12, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "0e79359e-e857-4087-9223-9daf1824b914", "evidence": "The slides highlighting leadership in AI and its impact on the company's work and innovation", "position": 0, "objective": "Why we are committed to AI-driven innovation", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/13", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-13", "loopMatches": [ { "to": 14, "from": 12, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "0e79359e-e857-4087-9223-9daf1824b914", "evidence": "The slides highlighting leadership in AI and its impact on the company's work and innovation", "position": 0, "objective": "Why we are committed to AI-driven innovation", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a navigation bar at the top to indicate the current section (Oncology).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/14", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-14", "loopMatches": [ { "to": 14, "from": 12, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "0e79359e-e857-4087-9223-9daf1824b914", "evidence": "The slides highlighting leadership in AI and its impact on the company's work and innovation", "position": 0, "objective": "Why we are committed to AI-driven innovation", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "kpi_overview", "function": "present_framework", "notes": "The slide uses a matrix structure to map drug assets (Imfinzi, Tagrisso, Enhertu, etc.) against patient segments and clinical trial names.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/15", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Includes Kaplan-Meier survival curves and bar charts for pCR rates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/16", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-16", "loopMatches": [ { "to": 17, "from": 16, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "7c254239-d2a1-4a86-a748-51d941a4fb83", "evidence": "The slides highlighting Oncology R&D highlights and progress", "position": 2, "objective": "Oncology R&D highlights", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "key_takeaways", "function": "summarize", "notes": "Slide 17 of a presentation deck. Includes detailed technical footnotes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/17", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-17", "loopMatches": [ { "to": 17, "from": 16, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "7c254239-d2a1-4a86-a748-51d941a4fb83", "evidence": "The slides highlighting Oncology R&D highlights and progress", "position": 2, "objective": "Oncology R&D highlights", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/18", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a consistent color-coded legend for products within each business unit chart.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/19", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "kpi_overview", "function": "analyze_data", "notes": "R&I = respiratory and immunology. The slide uses a combination of bar charts for individual product trends and a donut chart for total revenue context.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/20", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a color-coded legend to indicate development status (launched, approved/launch prep, Phase III, Phase II, Phase I).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/21", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "key_takeaways", "function": "summarize", "notes": "Slide 22 of a presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/22", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "before_after", "function": "present_solution", "notes": "The slide uses a before-after comparison to highlight the speed advantage of AI in identifying antibody leads.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/23", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-23", "loopMatches": [ { "to": 23, "from": 23, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "bc26a1b1-d7c2-4ac2-b0f2-a577fe44cfad", "evidence": "The before-after slide demonstrating the impact of AI in R&D", "position": 1, "objective": "The impact of AI in R&D", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "nominee_bio", "function": "introduce_nominees", "notes": "The slide features a portrait of the CEO and a scientific illustration of molecular structures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/24", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a stacked bar chart showing revenue trends by product over 7 quarters.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/25", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "key_messages", "function": "analyze_data", "notes": "Includes a stacked bar chart for Soliris registry data and a trial design schematic for gefurulimab.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/26", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 10, "beatId": "65085a95-2c38-4ee7-a364-a6a8cc62f676", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The slides showcasing progress in Oncology, BioPharmaceuticals, and Rare Disease provide satisfaction and demonstrate the company's growth", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "key_messages", "function": "present_solution", "notes": "Includes a biological pathway diagram and a table of drug assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/27", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 29, "from": 27, "beatId": "d4748166-ff02-4485-af4c-160000f223c2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "The closing remarks and key takeaways provide a visualization of the company's future prospects", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/28", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 29, "from": 27, "beatId": "d4748166-ff02-4485-af4c-160000f223c2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "The closing remarks and key takeaways provide a visualization of the company's future prospects", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a two-column layout to contrast near-term R&D milestones with long-term corporate strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/29", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 29, "from": 27, "beatId": "d4748166-ff02-4485-af4c-160000f223c2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Visualization", "beatSlug": "monroes-sequence-visualization", "evidence": "The closing remarks and key takeaways provide a visualization of the company's future prospects", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "other", "function": "other", "notes": "Slide 30 of a presentation, likely AstraZeneca given the executives listed.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/30", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/31", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "appendix", "function": "summarize", "notes": "The slide highlights 5 regulatory approvals and 1 positive CHMP opinion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/32", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "appendix_data", "function": "summarize", "notes": "Includes progress against specific 2025/2026 targets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/33", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart illustrates the impact of COVID-19 medicine revenue on total Emerging Markets performance over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/34", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data presented in stacked bar charts with corresponding data tables below each chart.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/35", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide contains two distinct charts: a stacked bar chart for product sales and a grouped bar chart for collaboration revenue.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/36", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data presented in stacked bar charts with corresponding data tables below each chart.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/37", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "appendix_data", "function": "analyze_data", "notes": "CER = constant exchange rates; EM = Emerging Markets; ERoW = Established Rest of World.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/38", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data presented as stacked bar charts with corresponding data tables below each chart.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/39", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "appendix_data", "function": "analyze_data", "notes": "CER = constant exchange rates; EM = Emerging Markets; ERoW = Established Rest of World.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/40", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-40", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ac90-73cc-861b-68f2ee02d519", "docSlug": "5e6566e4cd37b5a4c67661e229e01a81", "documentTitle": "AstraZeneca | Results Presentation Deck | 41 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data reflects post-acquisition reporting for Alexion products.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ac90-73cc-861b-68f2ee02d519/41", "deckHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519", "deckAnchorHref": "/decks/019de074-ac90-73cc-861b-68f2ee02d519#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/WbxNK7cqLU4Okm2bzC_gGSHrVXVgNFaJ3ElxHY3nqbI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMWFhZmRkYjM4ZDY0NTc0NWQxYzQwZDgzYjhhZTEzNS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/1", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/WfXxPMpi4ERMgb_axJ-Ng0P0QHTWnVa8tW4eToMt3TU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMWFhZmRkYjM4ZDY0NTc0NWQxYzQwZDgzYjhhZTEzNS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/F5HDamxtddXQcZuaf8e2bcn3sI2_ui3JLeAxks5L3Z8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMWFhZmRkYjM4ZDY0NTc0NWQxYzQwZDgzYjhhZTEzNS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/wdLNZaLTc_EhzWy-BGtzLoSk58V2JLBkSdTwPCB8L4k/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zMWFhZmRkYjM4ZDY0NTc0NWQxYzQwZDgzYjhhZTEzNS9wMDAxLnBuZw" }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": "Includes a footer note regarding the update date of March 24th, 2023.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/2", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a numbered list to present five key pillars of the company's value proposition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/3", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-3", "loopMatches": [ { "to": 30, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "8a640552-7d64-4f46-af4c-8041a39da251", "evidence": "The deck presents a clear and compelling vision for ATAI's mission and solution", "position": 1, "objective": "Present a compelling vision for ATAI's mission and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a hierarchical structure to connect a high-level objective to three specific strategic pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/4", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-4", "loopMatches": [ { "to": 30, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "8a640552-7d64-4f46-af4c-8041a39da251", "evidence": "The deck presents a clear and compelling vision for ATAI's mission and solution", "position": 1, "objective": "Present a compelling vision for ATAI's mission and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "1c0992d7-e43f-459f-9d09-bdda9fd2832c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 4-6 present the solution and roadmap for ATAI's pipeline", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to show drug development progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/5", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-5", "loopMatches": [ { "to": 30, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "8a640552-7d64-4f46-af4c-8041a39da251", "evidence": "The deck presents a clear and compelling vision for ATAI's mission and solution", "position": 1, "objective": "Present a compelling vision for ATAI's mission and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "1c0992d7-e43f-459f-9d09-bdda9fd2832c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 4-6 present the solution and roadmap for ATAI's pipeline", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 6, "from": 5, "beatId": "d382b620-7d12-4b58-8b29-e8666238cc7f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Roadmap", "beatSlug": null, "evidence": "Slides 5-6 present the roadmap for ATAI's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a timeline format to communicate both past achievements and future R&D milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/6", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-6", "loopMatches": [ { "to": 30, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "8a640552-7d64-4f46-af4c-8041a39da251", "evidence": "The deck presents a clear and compelling vision for ATAI's mission and solution", "position": 1, "objective": "Present a compelling vision for ATAI's mission and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "1c0992d7-e43f-459f-9d09-bdda9fd2832c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 4-6 present the solution and roadmap for ATAI's pipeline", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 6, "from": 5, "beatId": "d382b620-7d12-4b58-8b29-e8666238cc7f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Roadmap", "beatSlug": null, "evidence": "Slides 5-6 present the roadmap for ATAI's pipeline", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/7", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-7", "loopMatches": [ { "to": 30, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "8a640552-7d64-4f46-af4c-8041a39da251", "evidence": "The deck presents a clear and compelling vision for ATAI's mission and solution", "position": 1, "objective": "Present a compelling vision for ATAI's mission and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "problem_statement", "function": "frame_problem", "notes": "Uses a timeline-style vertical flow to represent the 'need' metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/8", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-8", "loopMatches": [ { "to": 9, "from": 8, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fb6c66f9-d6d2-4897-9f7b-06bc8c0c19e3", "evidence": "Slides 8-9 present the problem statement and highlight the need for innovation", "position": 0, "objective": "Highlight the need for innovation in mental health treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "8a640552-7d64-4f46-af4c-8041a39da251", "evidence": "The deck presents a clear and compelling vision for ATAI's mission and solution", "position": 1, "objective": "Present a compelling vision for ATAI's mission and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 9, "from": 8, "beatId": "7712450c-2d52-4158-ab49-c501275e7758", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 8-9 present the problem statement for CIAS and anxiety disorders", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "traction", "function": "show_traction", "notes": "Includes a quote from Keith Nuechterlein, Ph.D. regarding the clinical significance of the Symbol Coding results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/9", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-9", "loopMatches": [ { "to": 9, "from": 8, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "fb6c66f9-d6d2-4897-9f7b-06bc8c0c19e3", "evidence": "Slides 8-9 present the problem statement and highlight the need for innovation", "position": 0, "objective": "Highlight the need for innovation in mental health treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "8a640552-7d64-4f46-af4c-8041a39da251", "evidence": "The deck presents a clear and compelling vision for ATAI's mission and solution", "position": 1, "objective": "Present a compelling vision for ATAI's mission and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 9, "from": 8, "beatId": "7712450c-2d52-4158-ab49-c501275e7758", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slides 8-9 present the problem statement for CIAS and anxiety disorders", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 24, "from": 9, "beatId": "ac5e080c-b74d-4115-a83a-25ce54f0c50b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 9-24 present traction data for various programs", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a vertical process flow to show the progression of clinical trials and data validation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/10", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-10", "loopMatches": [ { "to": 30, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "8a640552-7d64-4f46-af4c-8041a39da251", "evidence": "The deck presents a clear and compelling vision for ATAI's mission and solution", "position": 1, "objective": "Present a compelling vision for ATAI's mission and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "ac5e080c-b74d-4115-a83a-25ce54f0c50b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 9-24 present traction data for various programs", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights the 'inverted-U' dose-response curve, a key pharmacological characteristic for this drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/11", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-11", "loopMatches": [ { "to": 30, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "8a640552-7d64-4f46-af4c-8041a39da251", "evidence": "The deck presents a clear and compelling vision for ATAI's mission and solution", "position": 1, "objective": "Present a compelling vision for ATAI's mission and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "ac5e080c-b74d-4115-a83a-25ce54f0c50b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 9-24 present traction data for various programs", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-ad31-7288-aa0c-b4a964d6a9af", "docSlug": "31aafddb38d645745d1c40d83b8ae135", "documentTitle": "ATAI | Investor Presentation Deck | 30 slides", "authorId": "atai", "authorName": "atai", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights that lower doses of RL-007 (40 or 80 mg TID) show statistically significant improvements compared to placebo in cognitive endpoints.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de074-ad31-7288-aa0c-b4a964d6a9af/12", "deckHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af", "deckAnchorHref": "/decks/019de074-ad31-7288-aa0c-b4a964d6a9af#slide-12", "loopMatches": [ { "to": 30, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "8a640552-7d64-4f46-af4c-8041a39da251", "evidence": "The deck presents a clear and compelling vision for ATAI's mission and solution", "position": 1, "objective": "Present a compelling vision for ATAI's mission and solution", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "ac5e080c-b74d-4115-a83a-25ce54f0c50b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 9-24 present traction data for various programs", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }